Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-07-16

Clinical Trial Update: Radiotherapy Combined With Oxaliplatin and Fluorouracil Followed By Gemcitabine in Treating Patients With Locally Advanced, Unresectable Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating radiotherapy with oxaliplatin and fluorouracil followed by gemcitabine in locally advanced, unresectable pancreatic cancer; the study h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 5-Fluorouracil (5-FU)
  • Eloxatin (oxaliplatin)
  • Gemzar (gemcitabine)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Adenocarcinoma of the Pancreas, Stage II Pancreatic Cancer | Phase 2 | Status: COMPLETED